inosine

Ukraine

Drugs containing this active substance

  • RIBOXIN

    The drug is used for the complex treatment of ischemic heart disease (post-infarction or in angina pectoris), cardiac rhythm disorders, cardiomyopathies, myocarditis, as well as liver diseases (hepatitis, cirrhosis, fatty dystrophy) and uroporphyria.

    Form: tablets, film-coated

    Active substance Dosage
    inosine 200 mg

    ATC: C01EB

    Manufacturer: PJSC "Halychpharm"

  • The drug is used for the complex treatment of ischemic heart disease (post-myocardial infarction, angina pectoris), cardiac rhythm disorders, cardiomyopathies, and myocarditis. It is also applied for liver diseases (hepatitis, cirrhosis, fatty dystrophy), for the prevention of leukopenia during radiation exposure, and to improve vision in glaucoma.

    Form: solution for injection

    Active substance Dosage
    inosine 20 mg/ml

    ATC: C01EB

    Manufacturer: PJSC "Halychpharm"

  • The drug is used for the complex treatment of ischemic heart disease (following myocardial infarction or in cases of angina pectoris), cardiac rhythm disorders, cardiomyopathies, myocarditis, as well as liver diseases (hepatitis, cirrhosis, fatty dystrophy) and uroporphyria.

    Form: tablets, film-coated

    Active substance Dosage
    inosine 200 mg

    ATC: C01EB

    Manufacturer: PJSC "Tekhnolog"

  • The drug is used as part of complex therapy for ischemic heart disease (after myocardial infarction or in angina pectoris), cardiac rhythm disorders, cardiomyopathies, myocarditis, as well as for liver diseases (hepatitis, cirrhosis, fatty dystrophy) and uroporphyria.

    Form: tablets, film-coated

    Active substance Dosage
    inosine 200 mg

    ATC: C01EB

    Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

  • The drug is used for the complex treatment of ischemic heart disease (post-infarction or in angina pectoris), cardiac rhythm disorders, cardiomyopathies, and myocarditis. It is also applied for liver diseases (hepatitis, cirrhosis, fatty dystrophy), to improve vision in glaucoma, and for the prevention of leukopenia during radiation exposure.

    Form: solution for injection

    Active substance Dosage
    inosine 20 mg/ml

    ATC: C01EB

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is used for the complex treatment of ischemic heart disease (after myocardial infarction or in angina pectoris), cardiac rhythm disorders, cardiomyopathies, myocarditis, as well as liver diseases (hepatitis, cirrhosis, fatty dystrophy) and uroprotoporphyria.

    Form: tablets, film-coated

    Active substance Dosage
    inosine 200 mg

    ATC: C01EB

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is used for the complex treatment of ischemic heart disease (after myocardial infarction or in angina pectoris), cardiac rhythm disorders, cardiomyopathies, myocarditis, as well as liver diseases (hepatitis, cirrhosis, fatty dystrophy) and uroproporphyria.

    Form: tablets, film-coated

    Active substance Dosage
    inosine 200 mg

    ATC: C01EB

    Manufacturer: JSC "Kyiv Vitamin Plant"